LetterThromboelastography Might Be More Applicable to Guide Anticoagulant Therapy than Fibrinolytic Therapy in Critically Ill Patients with COVID-19
Cited by (0)
Disclosure Information: Nothing to disclose.
Disclosures Outside the Scope of this Work: Dr Brubaker is supported by the NIH/NHLBI T32 HL139425; Dr Trautner is supported in part by the Center for Innovations in Quality, Effectiveness and Safety (CIN 13-413) at the Michael E DeBakey VA Medical Center. Dr Cruz is supported in part by the Center for Translational Research on Inflammatory Disease (CTRID), Michael E DeBakey VA Medical Center, and is the founder of A2 Therapeutics.
Disclaimer: The contents of this letter do not represent the views of the Department of Veterans Affairs or the US Government.
© 2021 by the American College of Surgeons. Published by Elsevier Inc. All rights reserved.